Molex Honored as a Supplier to the NeuroStar TMS Therapy System for the 2009 Medical Design Excellence Awards
02 Juni 2009 - 1:00PM
Business Wire
Molex Incorporated (NASDAQ: MOLX)(NASDAQ: MOLXA) today announced
it has been honored as a supplier to a winning product, the
NeuroStar TMS Therapy� system by Neuronetics Incorporated, in the
2009 Medical Design Excellence Awards (MDEA) competition, the
premier awards program for the medical technology community. The
MDEA will present the award on June 10 at the Medical Design &
Manufacturing East 2009 Conference and Exposition in New York
City.
�We are honored that Neuronetics chose us as a supplier for its
system and extremely pleased to be selected for this prestigious
award. Over the past four years, Molex has worked with Neuronetics
to improve and perfect the SenStar� Treatment Link assembly for
patient comfort and effectiveness,� said Justin Spitzer, business
development manager, Molex Incorporated. �This has culminated in
the NeuroStar TMS Therapy system being recently cleared by the U.S.
Food and Drug Administration for the treatment of major depressive
disorder in adult patients who have failed to achieve satisfactory
improvement from prior antidepressant medication.�
The NeuroStar TMS Therapy system is an electromagnetic medical
device for the treatment of major depressive disorder. It operates
by applying a focused, pulsed magnetic field that inductively
stimulates cortical neurons associated with depression.
The patented SenStar, supplied by Molex, is an integrated
flexible switch and circuit assembly which includes an x-y position
sensing, non-tactile membrane switch and a flexible circuit. The
switch portion provides feedback for proper positioning of the
Neurostar Treatment Coil while the flexible circuit reduces scalp
sensation during treatment.
Learn more about the 2009 Medical Design Excellence Awards at
http://www.devicelink.com/expo/awards/awards/index.php.
About Molex Incorporated
Molex Incorporated is a 70-year-old global manufacturer of
electronic, electrical and fiber optic interconnection systems.
Based in Lisle, Illinois, USA, the company operates 45
manufacturing locations in 17 countries. The Molex website is
www.molex.com.
About Molex User Interface Technology
Molex Incorporated is one of the world�s largest suppliers of
tactile and non-tactile membrane switches, LED and LCD display
assemblies, flexible circuits, dome arrays and control panel
assemblies, with global manufacturing capabilities. For additional
information on Molex�s user interface technology offering, please
visit: www.molex.com/product/switch.
Molex� is a registered trademark of Molex Incorporated.
NeuroStar TMS Therapy� and SenStar� are registered trademarks of
Neuronetics Incorporated.
Molex Incorporated (MM) (NASDAQ:MOLX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Molex Incorporated (MM) (NASDAQ:MOLX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024